Filing under Rule 425 under the U.S. Securities Act of 1933
Filing by: Daiichi Pharmaceutical Co., Ltd.
Subject Company: Daiichi Pharmaceutical Co., Ltd. and Sankyo Co., Ltd.
SEC File No. 132-02290
KIYOSHI MORITA
DAIICHI PHARMACEUTICAL COMPANY, LIMITED
Representative Director and President
CAREER
April 1962 | Joined Daiichi Pharmaceutical Co. Ltd. | |
April 1988 | General Manager, Marketing Information Department | |
April 1991 | General Manager, Sales Administration Department | |
June 1991 | Board Director | |
June 1995 | Managing Director, Pharmaceutical Marketing - Domestic | |
June 1997 | Representative Director/Senior Managing Director Administration, Pharmaceutical Marketing - Domestic | |
June 1999 | President | |
June 2003 | President and Chief Executive Officer | |
INDUSTRY ASSOCIATIONS
May 2003 | Standing Director | |
| Japan Pharmaceutical Manufacturers Association | ||
May 2004 | President and Chief Executive Officer | |
| The Pharmaceutical Manufacturers’ Association of Tokyo | ||
July 2004 | Executive Director | |
| Japan Business Federation | ||
TAKASHI SHODA
SANKYO COMPANY, LIMITED
Member of the Board
Representative Director and President
EDUCATION
Graduated from the faculty of Pharmacy, Tokyo University in March 1972
CAREER
| April 1972 | Joined SANKYO COMPANY, LIMITED | |
| January 1999 | Director, Department of Europe | |
| June 1999 | General Manager, International Pharmaceutical Division Director, Department of Europe | |
| August 2000 | General Manager, International Pharmaceutical Division Director, International Business Development Department | |
| June 2001 | Member of the Board General Manager, International Pharmaceutical Division Director, International Business Development Department | |
| June 2003 | Member of the Board | |
| Representative Director and President | ||
